BioSpace News Archive

Enrollment in the Phase 1/2 study is expected to begin in the first half of 2020.

Hiretual consolidates the top of the funnel with one Intelligent Talent Pipeline

The following table summarizes, for income tax purposes, the nature of cash distributions paid to stockholders during the calendar year ended December 31, 2019

The Company’s management will host a webcast to discuss the results at 8:15 a.m. ET on the same day.

Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning at 10:00 a.m. Eastern Time to discuss the results and answer questions.

AMELI-01 Clinical Trial Uses New UCART123 Construct With Optimized Production Process & New IND Number

This is the third breakthrough designation awarded to MedAlliance for its sirolimus DEB, following coronary in-stent restenosis and peripheral below-the-knee indications.

Dr. Quyen Ngo’s leadership at the Butler Center for Research will help advance knowledge and integrate addiction treatment research into practice [15-January-2020] CENTER CITY, Minn. , Jan. 15, 2020 /PRNewswire/ -- Dr. Quyen Ngo now leads research activities at the Hazelden Betty Ford Foundation as the new executive director of the Butler Center for Research .

CoImmune, Inc. and Formula Pharmaceuticals, Inc. announced the merger between the two companies, bringing together two therapeutic immuno-oncology platforms.

Modern Health announced the close of a $31 million Series B funding round to expand its holistic mental health benefits platform for employers.